Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial

Changes in Ki 67 expression after neoadjuvant therapy in HER2 positive breast cancer patients treated with trastuzumab and pertuzumab are independent predictors of response and prognosis

European Journal of Cancer ◽

10.1016/s0959-8049(18)30522-7 ◽

2018 ◽

Vol 92 ◽

pp. S98

Author(s):

I.T. Rubio ◽

A. Esgueva-Colmenarejo ◽

R. Rodriguez-Revuelto ◽

V. Peg ◽

V. Marco ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Ki 67 ◽

Predictors Of Response ◽

155P The addition of pyrotinib in early or locally advanced HER2-positive breast cancer patients with no response to two cycles of neoadjuvant therapy: A prospective, multicenter study

Annals of Oncology ◽

10.1016/j.annonc.2021.08.436 ◽

2021 ◽

Vol 32 ◽

pp. S428

Author(s):

Z.G. Yu ◽

B. Xiong ◽

Z. Yang ◽

L. Kong ◽

F. Wang ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Multicenter Study ◽

Locally Advanced ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Prospective Multicenter Study ◽

Four cycles of adriamycin and cyclophosphamide followed by four cycles of docetaxel (NSABP-B27) with concomitant trastuzumab as neoadjuvant therapy for high-risk, early-stage, HER2-positive breast cancer patients

OncoTargets and Therapy ◽

10.2147/ott.s151821 ◽

2018 ◽

Vol Volume 11 ◽

pp. 2091-2096 ◽

Cited By ~ 2

Author(s):

Hikmat Abdel-Razeq ◽

Salwa Saadeh ◽

Mahmoud Abu-Nasser ◽

Hazem Abdulelah ◽

Lina Marie ◽

...

Keyword(s):

Breast Cancer ◽

High Risk ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Early Stage ◽

Breast Cancer Patients ◽

Her2 Positive ◽

The Hippo Transducer YAP/TAZ as a Biomarker of Therapeutic Response and Prognosis in Trastuzumab-Based Neoadjuvant Therapy Treated HER2-Positive Breast Cancer Patients

Frontiers in Pharmacology ◽

10.3389/fphar.2020.537265 ◽

2020 ◽

Vol 11 ◽

Author(s):

Jia-qi Yuan ◽

Nian-hua Ding ◽

Zhi Xiao

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Therapeutic Response ◽

Breast Cancer Patients ◽

Her2 Positive ◽

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

Oncotarget ◽

10.18632/oncotarget.2449 ◽

2014 ◽

Vol 5 (20) ◽

pp. 9619-9625 ◽

Cited By ~ 22

Author(s):

Patrizia Vici ◽

Marcella Mottolese ◽

Laura Pizzuti ◽

Maddalena Barba ◽

Francesca Sperati ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Pathological Complete Response ◽

Complete Response ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Abstract P5-16-21: The association of higher tumor HER2 load with treatment response to neoadjuvant therapy in HER2 positive breast cancer patients

10.1158/1538-7445.sabcs16-p5-16-21 ◽

2017 ◽

Author(s):

TJ Lillemoe ◽

B Susnik ◽

E Grimm ◽

S-HL Kang ◽

KK Swenson ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Treatment Response ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients

Annals of Oncology ◽

10.1093/annonc/mdt364 ◽

2013 ◽

Vol 24 (12) ◽

pp. 2990-2994 ◽

Cited By ~ 55

Author(s):

V. Guarneri ◽

M.V. Dieci ◽

E. Barbieri ◽

F. Piacentini ◽

C. Omarini ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Her2 Positivity ◽

Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trial

BMC Medicine ◽

10.1186/s12916-018-1163-y ◽

2018 ◽

Vol 16 (1) ◽

Cited By ~ 33

Author(s):

Ines Stevic ◽

Volkmar Müller ◽

Karsten Weber ◽

Peter A. Fasching ◽

Thomas Karn ◽

...

Keyword(s):

Breast Cancer ◽

Neoadjuvant Therapy ◽

Cancer Patients ◽

Triple Negative ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with neoadjuvant chemotherapy: Sequential analysis

10.26226/morressier.596dfd55d462b80292386fa4 ◽

2017 ◽

Author(s):

You-Jeong Seo

Keyword(s):

Breast Cancer ◽

Neoadjuvant Chemotherapy ◽

Cancer Patients ◽

Sequential Analysis ◽

Breast Cancer Patients ◽

Her2 Positive ◽

Pik3ca Mutations ◽

Validation of the American Joint Committee on Cancer new prognostic stage groups for HER2-positive breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the prospective ShortHER trial

Annals of Oncology ◽

10.1093/annonc/mdz096.002 ◽

2019 ◽

Vol 30 ◽

pp. iii27-iii28

Author(s):

M.V. Dieci ◽

G. Bisagni ◽

A.A. Brandes ◽

A. Frassoldati ◽

M. Donadio ◽

...

Keyword(s):

Breast Cancer ◽

Adjuvant Chemotherapy ◽

Cancer Patients ◽

Breast Cancer Patients ◽

Her2 Positive ◽

American Joint Committee ◽